Mantle-Cell Lymphoma

Mantle cell lymphoma is an aggressive B-cell non-Hodgkin lymphoma that develops around the lymph node's outer edge known as the mantle zone. Here is the latest research on mantle cell lymphoma.

November 17, 2020

Expression and role of MIG/CXCR3 axis in mantle cell lymphoma

Experimental Cell Research
Ming-Xia ZhuHong-Mei Jing
December 4, 2020
Case Report
Open Access

Sustained Remission of Relapsed or Refractory Mantle Cell Lymphoma After 4-1BB-Based CD19-Directed CAR-T Therapy

OncoTargets and Therapy
Chunmei YangWenbin Qian
January 1, 2021
Review

Clinical efficacy and safety of first-line treatments in patients with mantle cell lymphoma: a systematic literature review

Critical Reviews in Oncology/hematology
Neerav MongaChristoph Tappric
December 2, 2020
Case Report

Haematological polyposis: mantle-cell lymphoma

Gastroenterología y hepatología
Pablo Cañamares OrbísCristina Borao Laguna
December 29, 2020

The M factor: maintenance in mantle cell lymphoma

The Lancet. Haematology
Martin Dreyling
December 12, 2020
Open Access

First report of the unique expression of RECAF (receptor for alfa feto-protein) in adult B-NHL/CLL patients

Blood Research
Hebatallah Adel SedkyWalaa Ali Elsalakawy
December 29, 2020
Review
Open Access

Role of Specific B-Cell Receptor Antigens in Lymphomagenesis

Frontiers in Oncology
Lorenz ThurnerMoritz Bewarder
January 5, 2021
Open Access

CXCR4 PET imaging of mantle cell lymphoma using [68 Ga]Pentixafor: comparison with [18 F]FDG-PET

Theranostics
Marius E MayerhoeferAlexander Haug
January 9, 2021
Open Access

Clinical characteristics and outcomes of primary versus secondary gastrointestinal mantle cell lymphoma

Blood Cancer Journal
Alessia CastellinoGrzegorz S Nowakowski
December 20, 2020

1,4,6-Trisubstituted imidazo[4,5-c]pyridines as inhibitors of Bruton's tyrosine kinase

European Journal of Medicinal Chemistry
Soňa KrajčovičováVladimír Kryštof
December 23, 2020

Cutaneous manifestations of mantle cell lymphoma: an extensive literature review

Acta Dermatovenerologica Alpina, Pannonica, Et Adriatica
Georgios GeropoulosTheodoros E Pavlidis
November 23, 2020
Preprint
Open Access

Improved SILAC quantification with data independent acquisition to investigate bortezomib-induced protein degradation

BioRxiv : the Preprint Server for Biology
L. K. PinoBenjamin A Garcia
November 21, 2020
Open Access

Frequency of MYD88 L256P mutation and its correlation with clinico-hematological profile in mature B-cell neoplasm

Hematology/oncology and Stem Cell Therapy
Raja ShekharPankaj Malhotra
December 29, 2020
Open Access

Detailed Long-Term Follow-Up of Patients Who Relapsed After the Nordic Mantle Cell Lymphoma Trials: MCL2 and MCL3

HemaSphere
Christian Winther EskelundKirsten Grønbæk
January 13, 2021
Review

Orally effective FDA-approved protein kinase targeted covalent inhibitors (TCIs)

Pharmacological Research : the Official Journal of the Italian Pharmacological Society
Robert Roskoski

Sign up to follow this feed and discover related papers.

Related Feeds

Acute Myeloid Leukaemia & RNA

Acute myeloid leukaemia (AML) is a common hematological type of cancer. As the population ages, there has been a rise in the frequency of AML. RNA expression has been used to see if there are different genetic profiles that exist within AML and whether these may underpin the variations in survival rates. Here is the latest research on AML and RNA.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Autoimmune Lymphoproliferative Syndrome

Autoimmune lymphoproliferative syndrome (ALPS) is a rare genetic disorder of abnormal lymphocyte survival caused by defective Fas mediated apoptosis. Discover the latest research on ALPS here.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

CNS Lymphoma

In CNS lymphoma, cancerous cells from lymph tissues or other parts of the body form tumors in the brain and/or spinal cord. Here is the latest research on this rare non-Hodgkin lymphoma.

Castleman Disease

Castleman disease is rare lymphoproliferative disorder unicentric (localized) or multicentric (systemic). Discover the latest research here.

Childhood Vascular Tumor: Genetics

Childhood vascular tumors are formed from cells related to blood vessels or lymph vessels. Here is the latest research on the genetics of childhood vascular tumors.

Chronic Myelogenous Leukemia

Chronic myelogenous leukemia (cml) is a clonal hematopoietic stem cell disorder characterized by the translocation and resultant production of the constitutively activated bcr-abl tyrosine kinase. Here is the latest research on this disease.

Composite Lymphoma

Composite Lymphoma involves different types of lymphoma cells concurrently. Here is the latest research on T-cell leukemia.

© 2021 Meta ULC. All rights reserved
/feed-previews/mantle-cell-lymphoma/d4b22f92-0209-496d-b1b9-83784181e621